SFI Health EMEA, the regional business of SFI Health, has launched Equazen food supplements in Portugal to support cognitive health.
Known for its clinically researched solutions, SFI Health specialises in microbiome, cognition, and well-being products.
Its Equazen brand provides science-backed nutritional solutions for brain health and cognitive function.
According to SFI Health, the products feature a blend of essential fatty acids (Omega-3 and Omega-6), supported by over 15 clinical studies demonstrating their ability to enhance learning, concentration, and healthy brain development.
The recent launch marks a milestone in SFI Health EMEA’s European expansion. This follows a license agreement signed in February 2024 with Eqyon Healthcare Solutions, a local distributor specialising in healthcare products.
The distributor will leverage its sales and marketing expertise to make the Equazen range available in pharmacies and parapharmacies.
Eqyon CEO Nuno Carvalho said: “We believe Equazen products will make a meaningful impact in our market, thanks to their high-quality ingredients and well-documented benefits.
“We are proud to bring Equazen back to Portugal and will work closely with SFI Health EMEA to strengthen confidence in natural solutions among healthcare professionals and consumers.”
SFI Health EMEA and Equazen are already present in several markets, including Spain, the UK, Switzerland, Poland, the Czech Republic, Slovakia, the Netherlands, the Nordics, and the Baltics.
The natural healthcare solutions company aims to expand Equazen distribution further to capitalise on the growing brain health supplements market and unlock the brand’s sales potential.
SFI Health EMEA general manager Matthew Brabazon said: “We are excited to offer our science-backed Equazen solutions to Portuguese consumers, who are becoming more proactive in supporting their cognitive needs.
“Our entry in Portugal is another step of our development plan to grow in the region by widening our partners network and customer base.”
